These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 22877223)

  • 1. Preclinical (1)H-MRS neurochemical profiling in neurological and psychiatric disorders.
    Lee MR; Denic A; Hinton DJ; Mishra PK; Choi DS; Pirko I; Rodriguez M; Macura SI
    Bioanalysis; 2012 Jul; 4(14):1787-804. PubMed ID: 22877223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative in vivo neurochemical profiling in humans: where are we now?
    McKay J; Tkáč I
    Int J Epidemiol; 2016 Oct; 45(5):1339-1350. PubMed ID: 27794521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications of magnetic resonance spectroscopy to the investigation of neuropsychiatric disorders.
    Dager SR; Steen RG
    Neuropsychopharmacology; 1992 Jun; 6(4):249-66. PubMed ID: 1632893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance spectroscopy studies of GABA in neuropsychiatric disorders.
    Chang L; Cloak CC; Ernst T
    J Clin Psychiatry; 2003; 64 Suppl 3():7-14. PubMed ID: 12662128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic characterization of neurological diseases by proton localized NMR spectroscopy of the human brain.
    Confort-Gouny S; Vion-Dury J; Nicoli F; Dano P; Gastaut JL; Cozzone PJ
    C R Acad Sci III; 1992; 315(7):287-93. PubMed ID: 1336428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance spectroscopy: current and future applications in psychiatric research.
    Lyoo IK; Renshaw PF
    Biol Psychiatry; 2002 Feb; 51(3):195-207. PubMed ID: 11839362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [N-acetylaspartate is a biomarker of psychiatric and neurological disorders].
    Baymeeva NV; Miroshnichenko II
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(8):94-98. PubMed ID: 26356622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research applications of magnetic resonance spectroscopy to investigate psychiatric disorders.
    Dager SR; Corrigan NM; Richards TL; Posse S
    Top Magn Reson Imaging; 2008 Apr; 19(2):81-96. PubMed ID: 19363431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI in animal models of psychiatric disorders.
    Poole DS; Oitzl MS; van der Weerd L
    Methods Mol Biol; 2011; 771():309-35. PubMed ID: 21874486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic Resonance Spectroscopy for Psychiatry: Progress in the Last Decade.
    Port JD
    Neuroimaging Clin N Am; 2020 Feb; 30(1):25-33. PubMed ID: 31759569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain GABA levels across psychiatric disorders: A systematic literature review and meta-analysis of (1) H-MRS studies.
    Schür RR; Draisma LW; Wijnen JP; Boks MP; Koevoets MG; Joëls M; Klomp DW; Kahn RS; Vinkers CH
    Hum Brain Mapp; 2016 Sep; 37(9):3337-52. PubMed ID: 27145016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multiparametric data analysis showing the potential of localized proton MR spectroscopy of the brain in the metabolic characterization of neurological diseases.
    Confort-Gouny S; Vion-Dury J; Nicoli F; Dano P; Donnet A; Grazziani N; Gastaut JL; Grisoli F; Cozzone PJ
    J Neurol Sci; 1993 Sep; 118(2):123-33. PubMed ID: 8229060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance spectroscopy in psychiatry: basic principles and applications.
    Frangou S; Williams SC
    Br Med Bull; 1996 Jul; 52(3):474-85. PubMed ID: 8949251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance spectroscopy in vivo: applications in neurological disorders.
    Arnold DL; De Stefano N
    Ital J Neurol Sci; 1997 Dec; 18(6):321-9. PubMed ID: 9494864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and resolution of brain lesions caused by pyrithiamine- and dietary-induced thiamine deficiency and alcohol exposure in the alcohol-preferring rat: a longitudinal magnetic resonance imaging and spectroscopy study.
    Pfefferbaum A; Adalsteinsson E; Bell RL; Sullivan EV
    Neuropsychopharmacology; 2007 May; 32(5):1159-77. PubMed ID: 16723995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain biochemistry using magnetic resonance spectroscopy: relevance to psychiatric illness in the elderly.
    Moore CM; Frederick BB; Renshaw PF
    J Geriatr Psychiatry Neurol; 1999; 12(3):107-17. PubMed ID: 10593699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR spectroscopy: a powerful tool for investigating brain function and neurological diseases.
    Burlina AP; Aureli T; Bracco F; Conti F; Battistin L
    Neurochem Res; 2000 Oct; 25(9-10):1365-72. PubMed ID: 11059807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance spectroscopy: neurochemistry and treatment effects in affective disorders.
    Moore GJ; Galloway MP
    Psychopharmacol Bull; 2002; 36(2):5-23. PubMed ID: 12397837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mood disorders: treatment-induced changes in brain neurochemistry and structure.
    Glitz DA; Manji HK; Moore GJ
    Semin Clin Neuropsychiatry; 2002 Oct; 7(4):269-80. PubMed ID: 12382209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of proton magnetic resonance spectroscopy in neurological diagnosis and neurotherapeutic decision making.
    Lin A; Ross BD; Harris K; Wong W
    NeuroRx; 2005 Apr; 2(2):197-214. PubMed ID: 15897945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.